Radial Extracorporeal Shock Wave Treatment (rESWT) of Myofascial Pain Syndrome in Low Back Pain
Prospective, Comparative, Randomized Study of the Effectiveness of Shock Wave Treatment in Myofascial Pain Syndrome in Low Back Pain
1 other identifier
interventional
46
1 country
1
Brief Summary
The purpose of this study is to evaluate the efficacy of treatment of radial shockwave in myofascial pain syndrome in the lumbar region compared to placebo through questionnaires and imaging exams.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jan 2013
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 7, 2013
CompletedFirst Submitted
Initial submission to the registry
April 14, 2013
CompletedFirst Posted
Study publicly available on registry
April 19, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 19, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
January 18, 2019
CompletedApril 30, 2019
April 1, 2019
5.2 years
April 14, 2013
April 27, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Evidence of pain relief by visual analogue scale (VAS) of radial extracorporeal shock waves in myofascial pain syndrome in the lumbar and gluteal region compared to placebo
The outcome will be assessed by Visual Analogue Scale (VAS)
12 weeks after the last session of shockwave
Study Arms (2)
Radial Extracorporeal Shock Wave
ACTIVE COMPARATORSwiss DolorClast® CLASSIC applicator
Placebo
PLACEBO COMPARATORSwiss DolorClast® CLASSIC placebo applicator
Interventions
Radial Extracorporeal Shock Wave applicator use in 6 sessions with 1 week of interval, 1000 impulses per myofascial trigger point, 5 to 7 hertz frequency, 2 to 4 bar pressure
Placebo applicator, use in 6 sessions with 1 week of interval, 1000 impulses per myofascial trigger point, 5 to 7 hertz frequency, 2 to 4 bar pressure
Eligibility Criteria
You may qualify if:
- Presenting clinical complaints of lumbar and / or gluteal pains for 3 months or more
- Display pain of moderate to severe intensity: visual analogue scale (VAS)\> 4
- Diagnosis of myofascial pain syndrome in the lumbar and / or gluteal
- Authorize in writing the term of free and informed consent to participate in the study
- Availability of frequent attendance at hospital
You may not qualify if:
- Organic or psychological disorders that contraindication participation of patients in study
- Metabolic, infectious, oncological or rheumatologic disorders
- Fibromyalgia
- Labor dispute
- Indication for surgery in column
- Contraindications to therapy of shock waves:
- Coagulopathy and / or anticoagulant
- Pregnancy
- Acute infection in soft tissue or bone
- Systemic Infections
- Presence of ulcers at treatment sites
- Presence of larger vessels or nerves at treatment sites
- Polyneuropathies
- Malignancies
- Cardiac arrhythmias or use of pacemaker
- +1 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
IOT HCFMUSP - Instituto de Ortopedia e Traumatologia do Hospital das Clínicas da Faculdade de Medicina da USP
São Paulo, 05403-010, Brazil
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Ricardo Kobayashi
IOT HCFMUSP - Instituto de Ortopedia e Traumatologia do Hospital das Clínicas da Faculdade de Medicina da USP
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Researcher and Collaborator of Pain Group
Study Record Dates
First Submitted
April 14, 2013
First Posted
April 19, 2013
Study Start
January 7, 2013
Primary Completion
March 19, 2018
Study Completion
January 18, 2019
Last Updated
April 30, 2019
Record last verified: 2019-04